Clinical Trial Update: Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating allogeneic hematopoietic cell transplantation from matched unrelated donor with reduced-intensity conditioning and co-transplantation o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diamond-blackfan Anemia
• Sickle Cell Disease
• Thalassemia

Drugs mentioned

• Allogeneic hematopoietic cell transplantation (matched unrelated donor) with reduced-intensity conditioning and mesenchymal stem cell co-transplantation

Snippet

Sponsor: Stanford University | Conditions: Sickle Cell Disease, Thalassemia | Phase 2 | Status: COMPLETED | Results posted: 2018-08-06